<DOC>
	<DOCNO>NCT03104062</DOCNO>
	<brief_summary>Of patient diagnose ST-segment elevation myocardial infarction ( STEMI ) underwent reperfusion therapy thrombolysis myocardial infarction ( TIMI ) 3 flow , 40 % flow alteration coronary microcirculation , lead bad remodel leave ventricle consequent increase mortality population . Clopidogrel known antiplatelet medication bring benefit coronary microcirculation . Ticagrelor significantly superior clopidogrel term decrease mortality . The main objective study compare effect ticagrelor versus clopidogrel coronary microcirculation Myocardial Perfusion Score Index ( MPSI ) obtain use Microbubble Contrasted Echocardiography ( MCE ) patient STEMI treat thrombolysis .</brief_summary>
	<brief_title>Effect Ticagrelor Clopidogrel Coronary Microcirculation Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description>The present project prospectively include patient participate TREAT study , include individual Acute Myocardial Infarction ( AMI ) treat fibrinolytic openly randomize ticagrelor clopidogrel within 24 hour onset symptom . Patients submit coronary angiography within 4 ( ± 2 ) day onset symptom , , end coronary angiography , present residual obstruction culprit vessel le 50 % TIMI 3 flow , regardless undergone percutaneous coronary intervention include . Following , day 2 ( ± 1 ) day coronary angiography ( therefore 6 ± 3 day onset symptom ) , submit microcirculation perfusion evaluation mean MPSI ( myocardial perfusion score index ) obtain MCE ( Microbubble contrast echocardiography ) - blood collection evaluation Platelet aggregability perform immediately prior start MCE . Finally , order evaluate leave ventricular remodeling , patient undergo new Echocardiography within 90 ( ± 10 ) day discharge .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>age 18 year old 75 year old . Patients STsegment elevation AMI 24 hour duration , document ischemic symptom due atherosclerosis &gt; 10 minute rest , treat pharmacological thrombolysis , acetylsalicylic acid ( ASA ) Clopidogrel Ticagrelor . Cardiac catheterization perform within 4 ( ± 2 ) day onset symptom , end coronary angiography show residual obstruction `` culprit '' artery &lt; 50 % TIMI 3 flow regardless whether percutaneous coronary intervention perform . Previous infarction know wall current one Any contraindication use Clopidogrel Ticagrelor Need oral anticoagulation therapy aspirin dose great 100mg per day . Concomitant oral intravenous therapy strong inhibitor Cytochrome P450 , family 3 , subfamily A ( CYP3A ) , Substrates CYP3A narrow therapeutic index strong inducer CYP3A High risk bradyarrhythmias Dialysis therapy Clinically important thrombocytopenia know Clinically Significant Anemia Pregnancy lactation Contraindications fibrinolytic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>